VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $863,000 | +50.9% | 41,563 | 0.0% | 1.32% | +42.3% |
| Q3 2017 | $572,000 | -20.4% | 41,563 | 0.0% | 0.93% | -16.4% |
| Q2 2017 | $719,000 | -21.5% | 41,563 | -50.0% | 1.11% | +85.7% |
| Q1 2017 | $916,000 | -22.0% | 83,126 | -19.2% | 0.60% | -22.6% |
| Q4 2016 | $1,174,000 | +15.1% | 102,868 | +147.5% | 0.78% | +1.8% |
| Q3 2016 | $1,020,000 | +21.9% | 41,563 | 0.0% | 0.76% | +36.6% |
| Q2 2016 | $837,000 | – | 41,563 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |